Medpace Holdings (MEDP) Depreciation & Amortization (CF) (2015 - 2026)

Medpace Holdings has reported Depreciation & Amortization (CF) for 12 years, with the latest figure at $6.8 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 0.85% year-over-year to $6.8 million; the trailing twelve-month figure through Mar 2026 stood at $27.3 million (down 2.17% YoY), and the FY2025 full-year result was $27.2 million, down 2.16% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $6.8 million, down from $6.9 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $7.2 million in Q3 2024, with the low at $4.3 million in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $6.2 million across 5 years, with a median of $6.6 million in 2024.
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) advanced 27.83% — and 2025, when it dropped 4.82%.
• Medpace Holdings' Depreciation & Amortization (CF) stood at $5.1 million in 2022, then grew by 26.04% to $6.4 million in 2023, then gained by 11.64% to $7.1 million in 2024, then fell by 3.1% to $6.9 million in 2025, then fell by 2.39% to $6.8 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $6.8 million (Q1 2026), $6.9 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.